drugset / Trial / NCT05478109
A Clinical Trial of XZP-3287 for Material Balance
NaSingle-groupOpen-labelOther
Summary
A single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of \[14C\] XZP-3287
Timeline
- Start
- 2022-08-02
- Primary completion
- 2023-01-04
- Completion
- 2023-01-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XZP-3287 | Unknown | 360 mg | Oral |
Indications
No indication recorded.